Keratin function and regulation in tissue homeostasis and pathogenesis

Biomolecular Concepts

Volumn 3, Issue 2, 2012, Pages 161-173

  Roth, Wera ^a   Hatzfeld, Mechthild ^b   Friedrich, Maik ^a   Thiering, Sören ^a   Magin, Thomas M ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

Author keywords

cell growth; keratins; posttranslational modification; protein biosynthesis; stress response

Indexed keywords

EID: 84891501261     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc.2011.060     Document Type: Review

References (81)

1. Gu LH, Coulombe PA. Keratin function in skin epithelia: a broadening palette with surprising shades. Curr Opin Cell Biol 2007; 19: 13-23.
2. Magin TM, Vijayaraj P, Leube RE. Structural and regulatory functions of keratins. Exp Cell Res 2007; 313: 2021-32.
3. Moll R, Divo M, Langbein L. The human keratins: biology and pathology. Histochem Cell Biol 2008; 129: 705-33.
4. Omary MB, Ku NO, Strnad P, Hanada S. Toward unraveling the complexity of simple epithelial keratins in human disease. J Clin Invest 2009; 119: 1794-805.
5. Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 2011; 30: 127-38.
6. Schweizer J, Bowden PE, Coulombe PA, Langbein L, Lane EB, Magin TM, Maltais L, Omary MB, Parry DAD, Rogers MA, Wright MW. New consensus nomenclature for mammalian keratins. J Cell Biol 2006; 174: 169-74.
7. Lee CH, Coulombe PA. Self-organization of keratin intermediate filaments into cross-linked networks. J Cell Biol 2009; 186: 409-21.
8. Fuchs E, Cleveland DW. A structural scaffolding of intermediate filaments in health and disease. Science 1998; 279: 514-9.
9. Szeverenyi I, Cassidy AJ, Chung CW, Lee BT, Common JE, Ogg SC, Chen H, Sim SY, Goh WLP, Ng KW, Simpson JA, Chee LL, Eng GH, Li B, Lunny DP, Chuon D, Venkatesh A, Khoo KH, McLean WHI, Lim YP, Lane EB. The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat 2008; 29: 351-60.
10. Hatzfeld M, Franke WW. Pair formation and promiscuity of cytokeratins: formation in vitro of heterotypic complexes and intermediate-sized filaments by homologous and heterologous recombinations of purified polypeptides. J Cell Biol 1985; 101(5 Pt 1): 1826-41.
11. Langbein L, Eckhart L, Rogers MA, Praetzel-Wunder S, Schweizer J. Against the rules: human keratin K80: two functional alternative splice variants, K80 and K80.1, with special cellular localization in a wide range of epithelia. J Biol Chem 2010; 285: 36909-21.
12. Birkenkamp-Demtroder K, Mansilla F, Sorensen FB, Kruhoffer M, Cabezon T, Christensen LL, Aaltonen LA, Verspaget HW, Orntoft TF. Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro. Mol Oncol 2007; 1: 181-95.
13. Liffers ST, Maghnouj A, Munding JB, Jackstadt R, Herbrand U, Schulenborg T, Marcus K, Klein-Scory S, Schmiegal W, Schwarte-Waldhoff I, Meyer HE, Stühler K, Hahn SA. Keratin 23, a novel DPC4/Smad4 target gene which binds 14-3-3epsilon. BMC Cancer 2011; 11: 137.
14. Sidhu GS, Chandra P, Cassai ND. Merkel cells, normal and neo-plastic: an update. Ultrastruct Pathol 2005; 29: 287-94.
15. Larouche D, Tong X, Fradette J, Coulombe PA, Germain L. Vibrissa hair bulge houses two populations of skin epithelial stem cells distinct by their keratin profile. FASEB J 2008; 22: 1404-15.
16. Magin TM, Reichelt J, Hatzfeld M. Emerging functions: diseases and animal models reshape our view of the cytoskeleton. Exp Cell Res 2004; 301: 91-102.
17. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol 2005; 6: 328-40.
18. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361: 496-509.
19. Wong P, Coulombe PA. Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. J Cell Biol 2003; 163: 327-37.
20. Kim S, Wong P, Coulombe PA. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature 2006; 441: 362-5.
21. Kerns ML, Depianto D, Dinkova-Kostova AT, Talalay P, Coulombe PA. Reprogramming of keratin biosynthesis by sul-foraphane restores skin integrity in epidermolysis bullosa simplex. Proc Natl Acad Sci USA 2007; 104: 14460-5.
22. Sykiotis GP, Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal 2010; 3: re3.
23. Kerns M, Depianto D, Yamamoto M, Coulombe PA. Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and-independent pathways in skin epithelia. Mol Biol Cell 2010; 21: 4068-75.
24. Buchan JR, Parker R. Eukaryotic stress granules: the ins and outs of translation. Mol Cell 2009; 36: 932-41.
25. Baird L, Dinkova-Kostova AT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 2011; 85: 241-72.
26. Oriolo AS, Wald FA, Ramsauer VP, Salas PJ. Intermediate filaments: a role in epithelial polarity. Exp Cell Res 2007; 313: 2255-64.
27. Magin TM, Reichelt J, Chen J. The role of keratins in epithelial homeostasis. In: Peter M. Elias, Kenneth R. Feingold, editors. Skin barrier. New York: Taylor & Francis, 2006: pp. 141-70.
28. Bader BL, Jahn L, Franke WW. Low level expression of cytok-eratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol 1988; 47: 300-19.
29. Kuruc N, Franke WW. Transient coexpression of desmin and cytokeratins 8 and 18 in developing myocardial cells of some vertebrate species. Differentiation 1988; 38: 177-93.
30. Stone MR, O'Neill A, Catino D, Bloch RJ. Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19. Mol Biol Cell 2005; 16: 4280-93.
31. Stone MR, O'Neill A, Lovering RM, Strong J, Resneck WG, Reed PW, Toivola DM, Ursitti JA, Omary MB, Bloch RJ. Absence of keratin 19 in mice causes skeletal myopathy with mitochondrial and sarcolemmal reorganization. J Cell Sci 2007; 120(Pt 22): 3999-4008.
32. Lovering RM, O'Neill A, Muriel JM, Prosser BL, Strong J, Bloch RJ. Physiology, structure, and susceptibility to injury of skeletal muscle in mice lacking keratin 19-based and desmin-based intermediate filaments. Am J Physiol Cell Physiol 2011; 300: C803-13.
33. Snider NT, Weerasinghe S V, Iniguez-Lluhi JA, Herrmann H, Omary MB. Keratin hypersumoylation alters filament dynamics and is a marker for human liver disease and keratin mutation. J Biol Chem 2011; 286: 2273-84.
34. Ku NO, Omary MB. A disease-and phosphorylation-related nonmechanical function for keratin 8. J Cell Biol 2006; 174: 115-25.
35. Menon MB, Schwermann J, Singh AK, Franz-Wachtel M, Pabst O, Seidler U, Omary MB, Kotlyarov A, Gaestel M. p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphory-late epithelial keratins. J Biol Chem 2010; 285: 33242-51.
36. Ku NO, Michie S, Resurreccion EZ, Broome RL, Omary MB. Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci USA 2002; 99: 4373-8.
37. Ridge KM, Linz L, Flitney FW, Kuczmarski ER, Chou YH, Omary MB, Sznajder JL, Goldman RD. Keratin 8 phosphoryla-tion by protein kinase C delta regulates shear stress-mediated disassembly of keratin intermediate filaments in alveolar epithelial cells. J Biol Chem 2005; 280: 30400-5.
38. Woll S, Windoffer R, Leube RE. p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells. J Cell Biol 2007; 177: 795-807.
39. Ku NO, Liao J, Omary MB. Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J 1998; 17: 1892-906.
40. Jaitovich A, Mehta S, Na N, Ciechanover A, Goldman RD, Ridge KM. Ubiquitin-proteasome-mediated degradation of keratin intermediate filaments in mechanically stimulated A549 cells. J Biol Chem 2008; 283: 25348-55.
41. Windoffer R, Beil M, Magin TM, Leube RE. Cytoskeleton in motion: the dynamics of keratin intermediate filaments in epithe-lia. J Cell Biol 2011; 194: 669-78.
42. Omary MB, Ku NO, Tao GZ, Toivola DM, Liao J. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem Sci 2006; 31: 383-94.
43. Vijayaraj P, Kroger C, Reuter U, Windoffer R, Leube RE, Magin TM. Keratins regulate protein biosynthesis through localization of GLUT1 and-3 upstream of AMP kinase and Raptor. J Cell Biol 2009; 187: 175-84.
44. Kroger C, Vijayaraj P, Reuter U, Windoffer R, Simmons D, Heukamp L, Leube R, Magin TM. Placental vasculogenesis is regulated by keratin-mediated hyperoxia in murine decidual tissues. Am J Pathol 2011; 178: 1578-90.
45. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 2010; 123(Pt 1): 13-22.
46. Ku NO, Toivola DM, Strnad P, Omary MB. Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat Cell Biol 2010; 12: 876-85.
47. Paramio JM, Segrelles C, Ruiz S, Jorcano JL. Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest. Mol Cell Biol 2001; 21: 7449-59.
48. Srikanth B, Vaidya MM, Kalraiya RD. O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18. J Biol Chem 2010; 285: 34062-71.
49. Melchior F. SUMO-nonclassical ubiquitin. Annu Rev Cell Dev Biol 2000; 16: 591-626.
50. Zhang YQ, Sarge KD. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardio-myopathies. J Cell Biol 2008; 182: 35-9.
51. Demarque MD, Nacerddine K, Neyret-Kahn H, Andrieux A, Danenberg E, Jouvion G, Bomme P, Hamard G, Romagnolo B, Terris B, Cumano A, Barker N, Clevers H, Dejean A. Sumoylation by Ubc9 regulates the stem cell compartment and structure and function of the intestinal epithelium in mice. Gastroenterology 2011; 140: 286-96.
52. Chisholm AD, Hardin J. Epidermal morphogenesis. In: Martin Chalfie, editors. WormBook. 2005: 1-22.
53. Kaminsky R, Denison C, Bening-Abu-Shach U, Chisholm AD, Gygi SP, Broday L. SUMO regulates the assembly and function of a cytoplasmic intermediate filament protein in C. elegans. Dev Cell 2009; 17: 724-35.
54. Zhang H, Landmann F, Zahreddine H, Rodriguez D, Koch M, Labouesse M. A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 2011; 471: 99-103.
55. Coulombe PA, Kerns ML, Fuchs E. Epidermolysis bullosa simplex: a paradigm for disorders of tissue fragility. J Clin Invest 2009; 119: 1784-93.
56. Herrmann H, Wedig T, Porter RM, Lane EB, Aebi U. Characterization of early assembly intermediates of recombinant human keratins. J Struct Biol 2002; 137: 82-96.
57. Lugassy J, Itin P, Ishida-Yamamoto A, Holland K, Huson S, Geiger D, Hennies HC, Indelman M, Bercovich D, Uitto J, Bergman R, McGrath JA, Richard G, Sprecher E. Naegeli-Franceschetti-Jadassohn syndrome and dermatopathia pigmentosa reticularis: two allelic ectodermal dysplasias caused by dominant mutations in KRT14. Am J Hum Genet 2006; 79: 724-30.
58. Titeux M, Decha A, Pironon N, Tonasso L, Gasc G, Mejia JE, Prost-Squarcioni C, Hovnanian A. A new case of keratin 14 functional knockout causes severe recessive EBS and questions the haploinsufficiency model of Naegeli-Franceschetti-Jadassohn syndrome. J Invest Dermatol 2011; 10: 2131-3.
59. Hofmann I, Herrmann H. Interference in vimentin assembly in vitro by synthetic peptides derived from the vimentin head domain. J Cell Sci 1992; 101(Pt 3): 687-700.
60. Lu H, Chen J, Planko L, Zigrino P, Klein-Hitpass L, Magin TM. Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS. J Invest Dermatol 2007; 127: 2781-9.
61. -/- mice and in human epidermolysis bullosa simplex. Hum Mutat 2009; 30: 832-41.
62. Liovic M, D'Alessandro M, Tomic-Canic M, Bolshakov VN, Coats SE, Lane EB. Severe keratin 5 and 14 mutations induce down-regulation of junction proteins in keratinocytes. Exp Cell Res 2009; 315: 2995-3003.
63. Arin MJ, Grimberg G, Schumann H, De AH Jr., Chang YR, Tadini G, Kohlhase J, Krieg T, Bruckner-Tuderman L, Has C. Identification of novel and known KRT5 and KRT14 mutations in 53 patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. Br J Dermatol 2010; 162: 1365-9.
64. Shiratsuchi H, Saito T, Sakamoto A, Itakura E, Tamiya S, Oshiro Y, Oda Y, Toh S, Komiyama S, Tsuneyoshi M. Mutation analysis of human cytokeratin 8 gene in malignant rhabdoid tumor: a possible association with intracytoplasmic inclusion body formation. Mod Pathol 2002; 15: 146-53.
65. Loffek S, Woll S, Hohfeld J, Leube RE, Has C, Bruckner-Tuderman L, Magin TM. The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation. Hum Mutat 2010; 31: 466-76.
66. Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010; 11: 515-28.
67. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer 2008; 8: 743-54.
68. Grachtchouk M, Mo R, Yu S, Zhang X, Sasaki H, Hui CC. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 2000; 24: 216-7.
69. Tong X, Coulombe PA. Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. Genes Dev 2006; 20: 1353-64.
70. Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet 2010; 42: 910-4.
71. Bianchi N, Depianto D, McGowan K, Gu C, Coulombe PA. Exploiting the keratin 17 gene promoter to visualize live cells in epithelial appendages of mice. Mol Cell Biol 2005; 25: 7249-59.
72. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 2007; 13: 139-45.
73. van de Rijn M, Perou CM, Tibshirani R, Haas P, Kallioniemi O, Kononen J, Torhorst T, Sauter G, Zuber M, Köchli OR. Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol 2002; 161: 1991-6.
74. Sarbia M, Fritze F, Geddert H, von WC, Rosenberg R, Gellert K. Differentiation between pancreaticobiliary and upper gastrointestinal adenocarcinomas: is analysis of cytokeratin 17 expression helpful? Am J Clin Pathol 2007; 128: 255-9.
75. Arin MJ, Oji V, Emmert S, Hausser I, Traupe H, Krieg T, Grimberg G. Expanding the keratin mutation database: novel and recurrent mutations and genotype-phenotype correlations in 28 patients with epidermolytic ichthyosis. Br J Dermatol 2011; 164: 442-7.
76. O'Regan GM, Sandilands A, McLean WH, Irvine AD. Filaggrin in atopic dermatitis. J Allergy Clin Immunol 2009; 124(3 Suppl 2): R2-6.
77. Chamcheu JC, Navsaria H, Pihl-Lundin I, Liovic M, Vahlquist A, Torma H. Chemical chaperones protect epidermolysis bullosa simplex keratinocytes from heat stress-induced keratin aggregation: involvement of heat shock proteins and MAP kinases. J Invest Dermatol 2011; 131: 1684-91.
78. Ku N-O, Omary MB. Identification and mutational analysis of the glycosylation sites of human keratin 18. J Biol Chem 1995; 270: 11820-7.
79. King IA, Hounsell EF. Cytokeratin 13 contains O-glycosidically linked N-acetylglucosamine residues. J Biol Chem 1989; 264: 14022-8.
80. Chou CF, Omary MB. Mitotic arrest-associated enhancement of O-linked glycosylation and phosphorylation of human keratins 8 and 18. J Biol Chem 1995; 268: 4465-72.
81. Wang Z, Udeshi ND, Slawson C, Compton PD, Sakabe K, Cheung WD, Shabanowitz J, Hunt DF, Hart GW. Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal 2010; 3: ra2.